Aktiesnakken — August 2012
-
Jeg har et depot hvor jeg har 183% profit på genmab. At man stadig er out of the money siger vist alt
-
duobody aftaler
-
@ sukker og andre gen nørder.
-
Janssen skriver de vil starte several phase III studies? hvilke indikationer kan Dara allerede gå i phase III ?
-
udover MM monotherapi?=
-
Haha i har glemt arzerra
-
Det er så insane at tænke på
-
sukker har du ikke set slides fra CC endnu?
-
jeg har linket dem til dig 2 gange
-
De er rigtigt spændnede. Der står også alle de indikationer de vil igang med
-
De skal beholde den fabrik
-
De skriver direkte 10 nye studier - several phase III - 3 nye indikationer og nævner så en masse mulige indikatioer
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind